Your browser doesn't support javascript.
loading
Safety and response after peptide receptor radionuclide therapy with 177 Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial.
Kudo, Atsushi; Tateishi, Ukihide; Yoshimura, Ryoichi; Tsuchiya, Junichi; Yokoyama, Kota; Takano, Shoko; Kobayashi, Noritoshi; Utsunomiya, Daisuke; Hata, Masaharu; Ichikawa, Yasushi; Tanabe, Minoru; Hosono, Makoto; Kinuya, Seigo.
Afiliação
  • Kudo A; Department of Hepatobiliary and Pancreatic Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Tateishi U; Department of Diagnostic Radiology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Yoshimura R; Department of Radiation Therapeutics and Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Tsuchiya J; Department of Diagnostic Radiology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Yokoyama K; Department of Diagnostic Radiology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Takano S; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kobayashi N; Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Utsunomiya D; Department of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Hata M; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Ichikawa Y; Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Tanabe M; Department of Hepatobiliary and Pancreatic Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Hosono M; Department of Radiation Oncology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
  • Kinuya S; Department of Nuclear Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
J Hepatobiliary Pancreat Sci ; 29(4): 487-499, 2022 Apr.
Article em En | MEDLINE | ID: mdl-34907652
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos Tipo de estudo: Observational_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos Tipo de estudo: Observational_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article